Skip to content
Catalyst

berberineFinding

Berberine inhibits NLRP3

lowersInsufficient evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“The qRT-PCR results showed that BBR dose-dependently inhibited the mRNA expression of NLRP3 and its linked molecules, including IL-1β, caspase-1, ASC, and GSDMAD.”
Quoted verbatim from Berberine inhibits NLRP3 inflammasome activation and proinflammatory macrophage M1 polarization to accelerate peripheral nerve regeneration.
This finding among the 3 findings on its endpoint

berberine

NLRP3

inhibits

Who
C57BL/6J mice with sciatic nerve crush injury (peripheral nerve injury), injury-site tissue
Dose studied
60-240 mg/kg/day, daily oral gavage, days 1-28

Insufficient evidencePMID 38570276 · 2024

02 · The study

Study
animal · not in humans
Duration
4 weeks

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limited
  • insufficientthis finding

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3P2TT9FXN58P9QM1XHTXMKY